Microbotulinum is effective for treating skin flaws, finds study
The results of a pilot study, published in the journal Plastic Reconstructive Surgery, have suggest that intradermal botulinum toxin injection, or so-called microbotulinum, is a safe and effective method to treat skin flaws.
Microbotulinum refers to the systematic injection of tiny blebs of diluted botulinum toxin at repeated intervals into the skin. This targets the superficial fibres of the facial muscles and weakens their insertion into the under-surface of the skin, which is responsible for fine lines and wrinkles on the face.
As part of the study, treatment was performed on 60 patients using a 32-gauge needle to deliver injections on a regular 1cm grid from the forehead to the cheek and down to the jawline.
All analysed parameters improved significantly (p < 0.0001) at 90 days with best results achieved in patients aged between 42.7 and 46.8 years.
The authors concluded that, because of the high satisfaction rate among both physicians and patients, further studies are mandatory to determine the optimal number of units needed for a longer and lasting effect with this particular novel dilution.
